Report Categories
View AllRecent Articles
View All
Is DistNow DNOW stock gaining momentum today Q4 2025 EPS Misses Estimates
TMCWW TMC the warrants lack earnings data as metals company navigates volatile commodity markets amid regulatory uncertainty
Oshkosh OSK Stock The Bull Case Sinks 20260415
Pinnacle PNFP Declines 149 Amid Market Weakness 20260515
Creator Content Takes Center Stage at TV Upfronts as Advertisers Target Younger Audiences
NexGel NXGL Q1 2026 Results Miss Estimates EPS 011 vs 007
Forbes 2026 AI 50 Unveils Leading Artificial Intelligence Companies Driving Global Innovation
Indian Markets Gain as Sentiment Improves Analysts Flag Potential Opportunities
Hanover THG Q1 2026 Beat Revenue NA EPS Exceeds by Significant
IBM Stock Leads MegaCap Declines in 2026 But Strong Earnings Raise Questions
DeepSeek Chinese AI Model Wins Praise From Silicon Valley Despite Chip Constraints
Mutual Fund SIPs Over OneThird of 2Year Investments Show Losses Data Reveals
SEBI Bars Seven Entities for Social MediaDriven Stock Manipulation Freezes 20 Crore Gains
Intuits Latest Earnings Could Challenge Morgan Stanleys Stock Forecast
Donald Trump JrBacked Enhanced Games Controversial Steroid Olympics Launches This Weekend with Broader Product Ambitions
Gold Prices Navigate Mixed Signals Amid Dollar Strength and Rate Expectations
SoftBank Taps Banks for US IPOs of SB Energy and AI Robotics Spinoff Roze Sources Confirm
Gogoro Q1 2026 Earnings Loss Per Share Widens Amid Challenging Market Conditions
Ovid Therapeutics Q1 2026 Earnings NarrowerThanExpected Loss Supports Biotechs Cash Discipline
GABC Q1 2026 Earnings EPS Misses Estimates Amid Ongoing Margin Pressure
PM Q1 2026 Earnings EPS Surpasses Estimates by 414
NEN Q4 2024 Earnings Partnership Delivers Strong PerUnit Earnings Amid Quiet Market Reaction
NPO Q1 2026 Earnings EPS Surpasses Estimates Shares Edge Higher
Enhabit Inc EHAB Holds Steady Near Support as Market Awaits Direction
Damora Therapeutics DMRA Holds Steady Near Support Technical Analysis of Key Levels
Global Industrial Company GIC Moves Higher Approaching Resistance at 3188
Akari Therapeutics AKTX Plunges 126 Amid Heightened Biotech Volatility
Green Brick Partners GRBK Gains 122 as Homebuilder Approaches Key Resistance